HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Elite 50% OFF Act now – get top investing tools Register Now!
Market News Stocks News ETF News Crypto News

ProPhase Labs, Inc.

Contributing Author

Recent Articles by ProPhase Labs, Inc.

Nov-26
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on December 1 PRPH GlobeNewswire
Nov-19
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. PRPH GlobeNewswire
Nov-18
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 PRPH GlobeNewswire
Nov-17
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals PRPH GlobeNewswire
Oct-29
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology PRPH GlobeNewswire
Oct-28
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts PRPH GlobeNewswire
Oct-24
ProPhase Labs to Present at the 2025 ThinkEquity Conference PRPH GlobeNewswire
Oct-22
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology PRPH GlobeNewswire
Sep-23
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE PRPH GlobeNewswire
Sep-22
ProPhase Continues its Exploration of a Crypto Treasury Strategy PRPH GlobeNewswire
Sep-12
ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor PRPH GlobeNewswire
Sep-03
ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025 PRPH GlobeNewswire
Aug-19
ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders PRPH GlobeNewswire
Aug-13
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025 PRPH GlobeNewswire
Aug-12
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment PRPH GlobeNewswire
Aug-11
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025 PRPH GlobeNewswire
Jul-29
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement PRPH GlobeNewswire
Jul-23
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing PRPH GlobeNewswire
Jul-21
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative PRPH GlobeNewswire
Jun-26
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule PRPH GlobeNewswire
Jun-17
ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart Test in Detecting Esophageal Cancer PRPH GlobeNewswire
Jun-06
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform PRPH GlobeNewswire
May-20
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 PRPH GlobeNewswire
May-13
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 PRPH GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.